PatientMatch — Privacy-first clinical trial discovery

Showing 1–24 of 161 trials

Enrolling now

Nationwide

A Dietary Study for People With Multiple Myeloma

Memorial Sloan Kettering Cancer Center

Lifestyle·~3yr·7 sites in NJ, NY

Why this is shown: Actively enrolling · 7 sites in NJ, NY

Enrolling now

Check if I qualify View study Official listing

Enrolling now

Check if I qualify

Nationwide

A Study Comparing Anitocabtagene Autoleucel to Standard of Care Therapy in Participants With Relapsed/ Refractory Multiple Myeloma

Kite, A Gilead Company

PHASE3·~7yr·50 sites in AZ, CA, CO +23

Why this is shown: Actively enrolling · PHASE3 · 50 sites in AZ, CA, CO +23

Enrolling now

Check if I qualify View study Official listing

Enrolling now

Check if I qualify

Nationwide

A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma

Janssen Research & Development, LLC

PHASE3·15 sites in CA, CT, FL +7

Why this is shown: Actively enrolling · PHASE3 · 15 sites in CA, CT, FL +7

Enrolling now

Check if I qualify View study Official listing

Enrolling now

Check if I qualify

Nationwide

A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma

K36 Therapeutics, Inc.

PHASE1·~3yr·13 sites in CA, FL, GA +8

Why this is shown: Actively enrolling · PHASE1 · 13 sites in CA, FL, GA +8

Enrolling now

Check if I qualify View study Official listing

Enrolling now

Check if I qualify

Nationwide

A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma

Janssen Research & Development, LLC

PHASE2·23 sites in AZ, CA, FL +11

Why this is shown: Actively enrolling · PHASE2 · 23 sites in AZ, CA, FL +11

Enrolling now

Check if I qualify View study Official listing

Enrolling now

Check if I qualify

Nationwide

A Study to Assess A Change in Disease Activity and Adverse Events of Intravenous Etentamig and Daratumumab (Etentamig+D) Compared to Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Adult Participants With Newly Diagnosed Multiple Myeloma Not Eligible for Transplant

AbbVie

Phase 2/3·~16yr·13 sites in AZ, CO, IN +7

Why this is shown: Actively enrolling · Phase 2/3 · 13 sites in AZ, CO, IN +7

Enrolling now

Check if I qualify View study Official listing

Enrolling now

Check if I qualify

Nationwide

A Study Comparing Iberdomide and Lenalidomide After Stem Cell Transplant for Multiple Myeloma

Bristol-Myers Squibb

PHASE3·~13yr·44 sites in CO, FL, GA +15

Why this is shown: Actively enrolling · PHASE3 · 44 sites in CO, FL, GA +15

Enrolling now

Check if I qualify View study Official listing

Enrolling now

Check if I qualify

Nationwide

A Study to Evaluate the Safety, PK/PD of OriCAR-017 in Subjects With RR/MM - RIGEL Study

OriCell Therapeutics Co., Ltd.

PHASE1·~4yr·1 site in GA

Why this is shown: Actively enrolling · PHASE1 · 1 site in GA

Enrolling now

Check if I qualify View study Official listing

Enrolling now

Check if I qualify

Nationwide

A Study to Examine the Effects of Novel Therapy Linvoseltamab in Combination With Other Cancer Treatments for Adult Patients With Multiple Myeloma That is Resistant to Current Standard of Care Treatments

Regeneron Pharmaceuticals

PHASE1·~12yr·13 sites in CA, GA, IN +8

Why this is shown: Actively enrolling · PHASE1 · 13 sites in CA, GA, IN +8

Enrolling now

Check if I qualify View study Official listing

Enrolling now

Check if I qualify

Nationwide

A Study to Learn About the Effects of the Combination of Elranatamab (PF-06863135) and Iberdomide in Patients With Relapsed or Refractory Multiple Myeloma (MagnetisMM-30)

Pfizer

PHASE1·~4yr·34 sites in FL, GA, IN +8

Why this is shown: Actively enrolling · PHASE1 · 34 sites in FL, GA, IN +8

Enrolling now

Check if I qualify View study Official listing

Enrolling now

Check if I qualify

Nationwide

A Window of Opportunity Trial to Learn if Linvoseltamab is Safe and Well Tolerated, and How Well it Works in Adult Participants With Recently Diagnosed Multiple Myeloma Who Have Not Already Received Treatment

Regeneron Pharmaceuticals

Phase 1/2·~12yr·13 sites in CA, CO, KY +5

Why this is shown: Actively enrolling · Phase 1/2 · 13 sites in CA, CO, KY +5

Enrolling now

Check if I qualify View study Official listing

Enrolling now

Check if I qualify

Nationwide

Gene Therapy Trial for Cancer

National Cancer Institute (NCI)

PHASE2·~10yr·1 site in MD

Why this is shown: Actively enrolling · PHASE2 · 1 site in MD

Enrolling now

Check if I qualify View study Official listing

Enrolling now

Check if I qualify

Nationwide

AZD0305 Trial

AstraZeneca

Phase 1/2·~3yr·9 sites in CA, GA, MA +5

Why this is shown: Actively enrolling · Phase 1/2 · 9 sites in CA, GA, MA +5

Enrolling now

Check if I qualify View study Official listing

Enrolling now

Check if I qualify

Nationwide

Evaluating Premedication Regimens (Methylprednisolone vs Dexamethasone-based) for the Prevention of Systemic and Injection Site Reactions to Motixafortide in Patients With Multiple Myeloma Undergoing Stem Cell Mobilization, PARADE Trial

Emory University

Procedure·PHASE4·~15mo·1 site in GA

Why this is shown: Actively enrolling · PHASE4 · 1 site in GA

Enrolling now

Check if I qualify View study Official listing

Enrolling now

Check if I qualify

Nationwide

Feasibility and Safety of Collecting Autologous Hematopoietic Stem Cells With Chimeric Antigen Receptor (CAR) T-Cell Therapy

Joshua Sasine, MD, PhD

PHASE1·~3yr·1 site in CA

Why this is shown: Actively enrolling · PHASE1 · 1 site in CA

Enrolling now

Check if I qualify View study Official listing

Enrolling now

Check if I qualify

Nationwide

Impact of Budesonide on Incidence of ≥ Gr2 Diarrhea in Multiple Myeloma (MM) Patients Undergoing Autologous Stem Cell Transplant

University of Utah

PHASE2·1 site in UT

Why this is shown: Actively enrolling · PHASE2 · 1 site in UT

Enrolling now

Check if I qualify View study Official listing

Enrolling now

Check if I qualify

Nationwide

Impact of Recombinant Human Interleukin-7 (CYT107) on Tumor Clearance and Immune Reconstitution in Multiple Myeloma Patients After Autologous Hematopoietic Cell Transplant

Washington University School of Medicine

Procedure·PHASE1·~4yr·1 site in MO

Why this is shown: Actively enrolling · PHASE1 · 1 site in MO

Enrolling now

Check if I qualify View study Official listing

Enrolling now

Check if I qualify

Nationwide

Improving Cognitive Function in Older Adults Undergoing Stem Cell Transplant

University of Nebraska

Lifestyle·~6yr·1 site in NE

Why this is shown: Actively enrolling · 1 site in NE

Enrolling now

Check if I qualify View study Official listing

Enrolling now

Check if I qualify

Nationwide

In-Human CXCR4 Imaging of Hematologic and Solid Tumors Using [68Ga]-Pentixafor-PET

Memorial Sloan Kettering Cancer Center

~5yr·1 site in NY

Why this is shown: Actively enrolling · 1 site in NY

Enrolling now

Check if I qualify View study Official listing

Enrolling now

Check if I qualify

Nationwide

Inobrodib, Pomalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma

CellCentric Ltd.

PHASE2·4 sites in GA, MD, NE +1

Why this is shown: Actively enrolling · PHASE2 · 4 sites in GA, MD, NE +1

Enrolling now

Check if I qualify View study Official listing

Enrolling now

Check if I qualify

Nationwide

Isatuximab During Stem Cell Collection and Transplant in Patients With Multiple Myeloma and Lymphoma

Divaya Bhutani

PHASE2·~4yr·2 sites in MI, NY

Why this is shown: Actively enrolling · PHASE2 · 2 sites in MI, NY

Enrolling now

Check if I qualify View study Official listing

Enrolling now

Check if I qualify

Nationwide

Mezigdomide (CC-92480) Post Idecabtagene Vicleucel in Treating Patients With Relapsed Multiple Myeloma

City of Hope Medical Center

Procedure·PHASE1·~2yr·1 site in CA

Why this is shown: Actively enrolling · PHASE1 · 1 site in CA

Enrolling now

Check if I qualify View study Official listing

Enrolling now

Check if I qualify

Nationwide

Mozobil for Autologous Hematopoietic Stem Cell Transplantation

Thomas Jefferson University

PHASE2·~3yr·1 site in PA

Why this is shown: Actively enrolling · PHASE2 · 1 site in PA

Enrolling now

Check if I qualify View study Official listing

Enrolling now

Check if I qualify

Nationwide

Phase 1/2 Study of Linvoseltamab in Adult Patients With Relapsed or Refractory Multiple Myeloma

Regeneron Pharmaceuticals

Phase 1/2·~14yr·14 sites in FL, GA, IN +8

Why this is shown: Actively enrolling · Phase 1/2 · 14 sites in FL, GA, IN +8

Enrolling now

Check if I qualify View study Official listing

Enrolling now

Check if I qualify